Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


CHMP positive recommendation for Ixchiq a Chikungunya vaccine – Valneva SE

Written by | 4 Jun 2024

Valneva SE a specialty vaccine company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion… read more.

FDA approval of world’s first chikungunya vaccine, Ixchiq – Valneva SE

Written by | 24 Nov 2023

Valneva SE announced that the FDA has approved Ixchiq, Valneva’s single-dose, live-attenuated vaccine indicated for the prevention of disease caused by chikungunya virus (CHIKV) in individuals 18 years… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.